Evidence map›Paper›PMID 30865493›Full record

ArticleCancer biotherapy & radiopharmaceuticals2019

Raquel Benedetto, Adriana V F Massicano, Bryant K Crenshaw, Renato Oliveira, Rui M Reis, Elaine B Araújo, Suzanne E Lapi

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer biotherapy & radiopharmaceuticals, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Assessment of CCR2 PET as a Biomarker for Head and Neck Squamous Cell Carcinoma.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. [Cancers · 2023
    Article
  7. Scientific reports · 2022
    Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Raquel Benedetto1 Instituto de Pesquisas Energéticas e Nucleares (IPEN), Sao Paulo, Brazil.
Adriana V F Massicano2 Department of Radiology, University of Alabama at Birmingham (UAB), Birmingham, Alabama.
Bryant K Crenshaw2 Department of Radiology, University of Alabama at Birmingham (UAB), Birmingham, Alabama.
Renato Oliveira3 Molecular Oncology Research Center, Barretos Cancer Hospital, Sao Paulo, Brazil.
Rui M Reis3 Molecular Oncology Research Center, Barretos Cancer Hospital, Sao Paulo, Brazil.
Elaine B Araújo1 Instituto de Pesquisas Energéticas e Nucleares (IPEN), Sao Paulo, Brazil.
Suzanne E Lapi2 Department of Radiology, University of Alabama at Birmingham (UAB), Birmingham, Alabama.
Hospital de Câncer de Barretos · BRInstituto de Pesquisas Energéticas e Nucleares · BRUniversity of Alabama at Birmingham · US

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Robert S Welner · 1985 to 2026
$165.9M
NCI NIH HHS P30 CA013148
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug Resistance, NeoplasmAnimalsApoptosisCell ProliferationCetuximabDeferoxamineFemaleHead and Neck NeoplasmsHumansMiceMice, NudeMolecular ImagingRadioisotopesRadiopharmaceuticalsSiderophoresSquamous Cell Carcinoma of Head and NeckCetuximabDeferoxamineRadioisotopesRadiopharmaceuticalsSiderophoresZirconiumZirconium-89cetuximabEGFRPET imagingresistancezirconium-89

Identifiers

PMID30865493
PMCPMC6588098
OpenAlexW2920819208

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.